DNAnexus Identified as Best-in-class in Global Precision Medicine Informatics

With its strong overall performance, DNAnexus earns Frost & Sullivan’s 2023 Global Company of the Year Award in the precision medicine informatics industry. DNAnexus excels in many of the criteria in the precision medicine informatics space.

Frost & Sullivan applies a rigorous analytical process to evaluate multiple nominees for each award category before determining the final award recipient.

• DNAnexus: Leading Biomedical Cloud-based Data Management and Analysis Platform
• Managing multi-omics and clinical data challenges
  
• Cultivating Innovation Through Collaboration and Co-Development for Customer Satisfaction
• Evolving from a Sequencing Data Processing Platform to a Nexus of Data and Science
  

“DNAnexus places a high degree of importance on providing customer satisfaction. The company understands that buying its software is just one part of a customer's journey and seeks to support its customers at every stage.” 
 
— Natalia Casanovas,Best Practices Research Analyst, Frost & Sullivan